Discrimination against children with severe allergies.
作者信息
Warner J O
出版信息
Pediatr Allergy Immunol. 2008 Dec;19(8):671-2. doi: 10.1111/j.1399-3038.2008.00840.x.
Abstract
摘要
相似文献
1
Discrimination against children with severe allergies.对严重过敏儿童的歧视。
Pediatr Allergy Immunol. 2008 Dec;19(8):671-2. doi: 10.1111/j.1399-3038.2008.00840.x.
2
Anti-IgE for asthma in inner-city children.抗IgE用于城市内儿童哮喘治疗
N Engl J Med. 2011 Jun 30;364(26):2557; author reply 2557-8. doi: 10.1056/NEJMc1104264.
3
Omalizumab for childhood asthma.奥马珠单抗用于儿童哮喘。
Expert Rev Respir Med. 2010 Feb;4(1):5-7. doi: 10.1586/ers.09.70.
4
NICE guidance on omalizumab for severe asthma.英国国家卫生与临床优化研究所关于奥马珠单抗治疗重度哮喘的指南。
Lancet Respir Med. 2013 May;1(3):189-90. doi: 10.1016/S2213-2600(13)70066-3. Epub 2013 Apr 24.
5
[Omalizumab in severe asthma--case report].
Pol Arch Med Wewn. 2006 Aug;116(2):766-70.
6
Summaries for patients. Omalizumab therapy for patients with severe asthma.患者摘要。重度哮喘患者的奥马珠单抗治疗。
Ann Intern Med. 2011 May 3;154(9):I28. doi: 10.7326/0003-4819-154-9-201105030-00001.
7
Omalizumab in asthma: is the therapeutic window too small?奥马珠单抗治疗哮喘：治疗窗是否过小？
Chest. 2011 Jan;139(1):8-10. doi: 10.1378/chest.10-2216.
8
World Asthma and COPD Forum. Clinical trial results with omalizumab.世界哮喘与慢性阻塞性肺疾病论坛。奥马珠单抗的临床试验结果。
IDrugs. 2008 Jul;11(7):489-92.
9
Omalizumab has a place in therapy for asthma disease management.奥马珠单抗在哮喘疾病管理的治疗中占有一席之地。
J Manag Care Pharm. 2009 Apr;15(3):284-8. doi: 10.18553/jmcp.2009.15.3.284.
10
Anti-IgE for asthma in inner-city children.用于城市内儿童哮喘治疗的抗IgE药物
N Engl J Med. 2011 Jun 30;364(26):2556-7; author reply 2557-8. doi: 10.1056/NEJMc1104264.
Zotero 插件